# Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

> **NCT04934514** · PHASE1,PHASE2 · UNKNOWN · sponsor: **SUNHO（China）BioPharmaceutical CO., Ltd.** · enrollment: 97 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** IAH0968
- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT04934514
- **Lead sponsor:** SUNHO（China）BioPharmaceutical CO., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-06
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04934514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04934514, "Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04934514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*